Company Overview

Update
Headquarters:
New York, NY
Funding:
$500k
Categories:
Biotechnology
Description:
AndroBioSys is a biotechnology company that focuses on the development of novel treatments for prostate disease.

Detailed Description

Update

AndroBioSys, Inc. (ABS), is a biotechnology company dedicated to the development of novel treatments for prostate disease. Based on technologies developed at Roswell Park Cancer Institute, AndroBioSys is pioneering new approaches to make treatment of prostate cancer curative, not palliative. Preventing progression of prostate disease is intertwined intimately with disruption of the androgen axis. ABS performs contract research screening services for academic, biotechnology and pharmaceutical clients and develops collaborative partnerships to discover new drugs to proprietary prostate disease targets.

Past Team (1)

Update

Investors (3)

Update

Offices/Locations (1)

Update
  • Office

    73 High St. Buffalo, NY 14203

    New York, NY 14203

    USA

Images (1)

Update
  • 2b6802bfdd20394b4d3ca30a6f19fad9